PharmiWeb.com - Global Pharma News & Resources
01-Apr-2019

Glycated Hemoglobin Testing Market 2019 Global Cumulative Revenue (2017-2026) US$ 650 Million

The global glycated hemoglobin testing market is projected to reach a value of over US$ 650 Mn in 2026 at a CAGR of 8.6% over the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global glycated hemoglobin testing market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2026.

Glycated hemoglobin testing is used to measure concentration of blood glucose in individuals. HbA1c, is a chemical form of glycated hemoglobin, a protein within red blood cells that carries oxygen throughout your body, joins with glucose in the blood, becoming ‘glycated’. It is used to determine average glucose level in person’s blood over a period of time. Glycosylated hemoglobin test shows person’s average blood glucose level for two to three months before the test. This can help to determine how well a person’s diabetes is being controlled over time. High blood glucose level causes glucose molecules to attach the hemoglobin in red blood cells.

Increasing prevalence of diabetes mellitus and development in diagnosis devices for diabetes are major factors driving growth of the global glycated hemoglobin testing market. In addition, rising demand for rapid diagnostics tools and growing home healthcare market are other major factors expected to drive growth of the global glycated hemoglobin testing market over the forecast period.

Ongoing trend observed in the market is the increasing preference for point of care (POC) HbA1c testing among the users, owing to factors such as faster test results and enables faster prognosis of the associated disease in the patient. This testing has been majorly adopted by the diabetes clinics across the may improve patient adherence by lessening transportation time and cost barriers associated with extra office and laboratory visits.

Get Free Sample Copy Of This Research @ https://marketresearch.biz/report/glycated-hemoglobin-testing-market/request-sample/

The global glycated hemoglobin testing market is segmented on the basis of type, technique, end user, and region.

On the basis of type segmentation, lab based test segment is expected to contribute major revenue share and CAGR of over 7.5%, in terms of revenue over the forecast period. The point-of-care test segment in the global glycated hemoglobin testing market is expected to register highest CAGR of over 8%, in terms of revenue over the forecast period.

Among technique segments, immunoassay segment is expected to register highest CAGR of 8% owing to increasing preference for immunoassay technique as it is affordable, and easy to operate. Chromatography segment in the global glycated hemoglobin testing market is accounted for largest market share in terms of revenue over the forecast period.

Among end user segments, hospital segment is expected to contribute major revenue share and witness highest CAGR of over 4.0%, in terms of revenue over the forecast period, owing to presence of both lab-based testing and point-of-care testing (POCT) facilities at single point

North America market is expected to dominate the global glycated hemoglobin testing market, and accounts for largest market revenue share over 30% in 2017 as compared to that of markets in other regions. Dominance by North America market is expected to continue over the forecast period owing to higher demand from consumers in countries such as the US and Canada. Other factors include presence of leading manufacturers in these countries, and an increasing consumer base adopting portable point-of-care testing (POCT) devices in countries in this region.

Technological advancements in glycated hemoglobin testing market, coupled with prominent manufacturers developing portable testing devices are other major factors expected to boost growth of the North America glycated hemoglobin testing market over the forecast period. In 2015 for instance, Bio-Rad Laboratories, Inc. launched its VARIANT II TURBO HbA1c Kit – 2.0 for diagnosing diabetes.

For Purchasing The Report Click Here: https://marketresearch.biz/purchase-report/?report_id=4060

Prominent players in the Glycated Hemoglobin Testing Market are Abbott Laboratories, Alere, Danaher, Hoffmann-La Roche, Beckman Coulter, Inc., Bio-Rad Laboratories, Arkray, Bayer AG, Tosoh Corporation, Siemens AG..

Editor Details

Last Updated: 01-Apr-2019